Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain.

Healy P, Verrest L, Felisi M, Ceci A, Della Pasqua O, GAPP Consortium.

Open source

DOI: 10.1002/prp2.1138
Published: 2023-10-01
Container: Pharmacol Res Perspect
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/prp2.1138,
  title = {Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain.},
  author = {Healy P and  Verrest L and  Felisi M and  Ceci A and  Della Pasqua O and  GAPP Consortium.},
  year = {2023},
  journal = {Pharmacol Res Perspect},
  doi = {10.1002/prp2.1138},
  url = {https://doi.org/10.1002/prp2.1138}
}

RIS

TY  - JOUR
TI  - Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain.
AU  - Healy P
AU  -  Verrest L
AU  -  Felisi M
AU  -  Ceci A
AU  -  Della Pasqua O
AU  -  GAPP Consortium.
PY  - 2023
JO  - Pharmacol Res Perspect
DO  - 10.1002/prp2.1138
UR  - https://doi.org/10.1002/prp2.1138
ER  -

APA

P, H., L, V., M, F., A, C., O, D. P., & Consortium., G. (2023). Dose rationale for gabapentin and tramadol in pediatric patients with chronic pain.. Pharmacol Res Perspect. https://doi.org/10.1002/prp2.1138

Source records

europe-pmc · retrieved 2026-09-27T06:14:31.719Z
doaj · retrieved 2026-09-27T06:14:31.736Z